Abstract:Purpose: Recently, emerging evidences have shown that microbiome might play an important role in the pathogenesis of osteoarthritis (OA). Previously, we have proposed a two-hit model of OA pathogenesis and potentiation in which shifts of gut microbiome acted the innate immune response as one hit. Another hit results from joint damage that releases a lot of damage associated with molecular patterns (DAMPs), resulting in a synergistic activation of inflammatory pathways leading to OA. The current study was aimed to prove our two-hit hypothesis. Methods: Basic information, fecal and blood samples were collected in three different groups of people: health control, OA without metabolic syndrome (MS), OA with metabolic syndrome. Low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG) and cholesterol (CHOL) were detected in the blood samples. 16S RNA sequencing was used to profile the composition of microbiome in fecal samples and compared in groups. Based on different types of fecal transplantation and surgical treatments, thirty-nine germ free mice were divided into following groups: 1) Group 1: transplanted with sterile water for 7 days then MLI model was induced; 2) Group 2: transplanted with fecal samples from people of health control group and sham surgery was induced; 3) Group 3: transplanted with fecal samples from people of health control group and MLI model was induced; 4) Group 4: transplanted with fecal samples from patients of OA without MS group and MLI model was induced; 5) Group 5: transplanted with fecal samples from patients of OA with MS group and MLI model was induced. Mice were sacrificed 6 weeks following surgery. All the knee joints, blood samples, small intestine and colon were collected. Customized inflammatory biomarkers panel (Milliplex®) was used to detect inflammatory biomarkers in the blood samples. Also, lipopolysaccharide (LPS) and lipopolysaccharide binding protein were also detected in the blood samples. Knee joints were processed for histology analysis and stained in Safranin O for OARSI scoring. 16S RNA sequencing was applied in fecal samples collected from both small intestine and colon for microbiome profiling and compared in groups. FISH was used to visualize the change of permeability of colonic mucosa. Data were analyzed using Kruskal-Wallis test. Spearman correlations were calculated between inflammatory biomarkers, OARSI scores and microbiome profiles. Results: Totally nineteen patients were recruited, 4 in the health control group, 7 in the OA without MS group and 8 in the OA with MS group. Significant higher BMI (p<0.001), LDL (p=0.007) and TG level (p=0.015) were founded in the OA with MS group. Significant lower HDL level was found in the OA with MS group compared to the other two groups (p=0.034). Microbiome profile showed no significant differences between three groups in terms of αdiversity. While significant differences in terms of β diversity was found (p=0.036). Histology analysis of the mice knee joints showed significant lower OARSI score in Group 1 and Group 2 compared with the other three groups (Figure 1). While Group 5 has the highest OARSI score compared with Group 3 and 4 (Figure 1). Inflammatory biomarkers analysis showed significant higher IL-1βand MCP-1 were founded in Group 5 (Figure 2). Significant lower αdiversity of microbiome was found in Group 5. While significant differences in terms of β diversity was also founded between groups. Correlations between OARSI score, biomarkers and microbiome profile showed that both Anaerostipes and Fusobacterium had significant positive correlations with inflammatory biomarkers and histological severity. Also Fusobacterium had a significant negative correlation with inflammatory biomarkers and histological severity. Conclusions: 1) Germ-free will alleviate the severity of OA in mice model; 2) IL-1βand MCP-1 might play an important role in germ-free protection; 3) Anaerostipes and Fusobacterium might be the cause of the MS associated OA. While Fusobacterium can protect people from MS associated OA. Further mechanism needs future explorations.View Large Image Figure ViewerDownload Hi-res image Download (PPT)

Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model

Periodontitis As a Novel Contributor of Adipose Tissue Inflammation Promotes Insulin Resistance in a Rat Model

Taxonomic changes in the gut microbiota are associated with cartilage damage independent of adiposity, high fat diet, and joint injury

Immunometabolic capacities of nutritional fatty acids in regulation of inflammatory bone cell interaction and systemic impact of periodontal infection

Gut microbiota and obesity-associated osteoarthritis

Association of low-grade inflammation caused by gut microbiota disturbances with osteoarthritis: A systematic review

The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration of Chondroitin Sulfate and Probiotic

Gut microbiome and osteoarthritis: insights from the naturally occurring canine model of OA

Free lipoproteins from Bifidobacterium longum alleviate osteoarthritis through modulation of the gut microbiome

The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature

Changes in the Serum Metabolome in an Inflammatory Model of Osteoarthritis in Rats

OSTEOARTHRITIS INDUCED BY MENISCAL/LIGAMENTOUS INJURY IS AGGRAVATED AFTER METABOLIC SYNDROME FECAL SAMPLE TRANSPLANTATION IN GERM-FREE MICE

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation

High fat diet increases the severity of collagen-induced arthritis in mice by altering the gut microbial community

A correlation between intestinal microbiota dysbiosis and osteoarthritis

The causal role of gut microbiota in development of osteoarthritis

Dietary Fatty Acid Regulation of the NLRP3 Inflammasome via the TLR4/NF-κB Signaling Pathway Affects Chondrocyte Pyroptosis

Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice

Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics

The gut microbiota in osteoarthritis: where do we stand and what can we do?

Gut-microbiota modulation: The impact of thegut-microbiotaon osteoarthritis